Relationship between changes in bone mineral density and fracture risk reduction with antiresorptive drugs: some issues with meta-analyses.
UNLABELLED: Published meta-analyses have investigated the relationship between changes in BMD and fracture risk reduction observed with antiresorptive agents, with inconsistent results. Many factors may affect the outcome of such analyses. Our work explores some of these factors and illustrates the...
Main Authors: | Delmas, P, Li, Z, Cooper, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2004
|
Similar Items
-
Trabecular Bone Score Improves Early After Successful Kidney Transplantation Irrespective of Antiresorptive Therapy and Changes in Bone Mineral Density
by: Ruth C. Strømmen, MBBS, et al.
Published: (2024-01-01) -
The biological mechanisms of the antiresorptive therapy of osteoporosis, and the antiresorptive drug related osteonecrosis of jaws
by: István Gera, et al.
Published: (2024-03-01) -
Risk of Fracture and Bone Mineral Density in Stroke Response
by: Pouwels, S, et al.
Published: (2010) -
Management of Tooth Extraction in Patients Taking Antiresorptive Drugs: An Evidence Mapping Review and Meta-Analysis
by: Chang Liu, et al.
Published: (2022-12-01) -
Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk.
by: Watts, N, et al.
Published: (2004)